Two new programs aim to boost local bioscience firms

Westwood-based UCLA Health, in partnership with Culver City-based BioscienceLA and UCLA Biodesign announced Feb. 15 the launch of a new accelerator with a program combining health equity and technology. The UCLA Health TechQuity Accelerator will seek to combine clinical excellence and innovation for diverse patient populations, part of an effort to support long-term community health resilience as the Covid-19 pandemic appears to be receding.

TechQuity is inviting early stage startups to apply to its first cohort, which is set to launch on May 1. The four-month program will provide founders with personalized mentorship, access to clinical expertise and product development support. It will culminate in a final pitch showcase featuring UCLA Health leaders and community stakeholders. TechQuity plans to draw upon the tech ecosystem in Los Angeles County, including its talent pool, assets and infrastructure.

“Through technology-driven innovation, we’re targeting four thematic areas — prevention, diagnosis, treatment and community impact — and although this effort began in response to Covid-19’s impact on under-resourced communities, we’re building it to be sustainable, to provide better health security beyond the pandemic,” Jennifer McCaney, executive director of UCLA Biodesign and assistant director of the UCLA Clinical and Translational Science Institute, said in the announcement.

The incubator within the Lundquist Institute quietly launched last May under a new company called Brazen Bio Inc., which is also located within the institute. According to Brazen Bio co-founder and Chief Executive Shawn Carbonell, the incubator is devoted exclusively to cultivating the creative energy and business acumen of bioscience company founders.

Jennifer McCaney is also co-leader for the CTSI Workforce Development Program. 

See the full press release.

image caption: Jennifer McCaney, PhD

Image source: UCLA